Dr. Seyed Mohammad Reza M. Monemian, MD

Dr. Monemian practices at Southern California Permanente Medical Group in Lancaster, California.

Dr. Monemian's NPI, 1295953685, was assigned on April 23, 2007. Dr. Monemian graduated from Iran University of Medical Sciences in 1998. Dr. Monemian holds California license A115584.

Dr. Monemian's primary practice is Southern California Permanente Medical Group, at 43112 15th W St, Lancaster, CA 93534 in Los Angeles County. The practice phone is (661) 726-2279.

Dr. Monemian's primary practice is Southern California Permanente Medical Group in Lancaster, California. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Dr. Monemian to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Monemian practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Monemian's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Monemian is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Monemian's licenses on file in 4 states: California, Hawaii, Georgia and New York.

CMS data shows 41 Medicare services from Dr. Monemian across 1 procedure code in 2023, for 14 Medicare patients. Medicare paid $81 for them. Every service was in an office.

CMS counts 14 Medicare patients who saw Dr. Monemian in 2024. The largest group is 85 and over, with 0 patients. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Monemian's median patient age at 59, with 72% women.

In 2024, Dr. Monemian wrote 1,007 Medicare Part D claims for 205 patients. 77% of them were for generic drugs. CMS names the drug for 861 of them, across 18 drugs with 11 or more claims each, at $2,246,438 in total drug cost. In 2023, CMS named 690 claims across 15 drugs.

Dr. Monemian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Monemian as offering telehealth.

Dmand AI links 1 paper to Dr. Monemian in 2008.

CMS Open Payments shows 6 general payments to Dr. Monemian from 6 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 100% of the total. Aadi Bioscience, Inc. paid the most, $130.

Dmand AI lists 1 award for Dr. Monemian, most recently CMS Stage 1 2012 in 2011.

Dr. Monemian graduated from Iran University of Medical Sciences in 1998.

Dr. Monemian is in network with 2 carriers, including Kaiser Permanente and CMS Medicare. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.